From Cincinnati Children’s e-Newsletter
An excerpt:
New Test Expedites the Diagnosis of Biliary Atresia
A groundbreaking test developed at Cincinnati Children’s can expedite a diagnosis of biliary atresia (BA), helping physicians decide quickly whether to perform a liver biopsy followed by an operative cholangiogram, the definitive test for BA. The test quantifies the concentration of MMP-7 (matrix metalloproteinase-7), a serum protein that researchers at Cincinnati Children’s discovered in 2017 is a biomarker of BA.
Physicians can order the MMP-7 assay by submitting a requisition form. Test results are available within 48 hours, and a pediatric hepatologist is always available for consultation regarding the interpretation of test results.
Related blog posts:
- New Way to Diagnose Biliary Atresia
- Blood Test is Better Than a Liver Biopsy for Bilary Atresia
- Will We Still Need a Liver Biopsy to Diagnose Biliary Atresia in a Few Years?
- Helpful Review on Biliary Atresia | gutsandgrowth
- Newborn bilirubin measurements for biliary atresia
gutsandgrowth 
Is this covered by insurance? How would blood be drawn if your not at a university or hospital lab?
I have been told that the cost is as low as $290. I would contact Cincinatti directly with other questions.
Pingback: What Is The Evidence That Biliary Atresia Starts in Utero? | gutsandgrowth
Pingback: 30 -Year Outcomes with Biliary Atresia | gutsandgrowth
Pingback: Precision Prediction of Biliary Atresia Survival | gutsandgrowth
Pingback: 2020 AASLD President: Jorge Bezerra | gutsandgrowth